vs
Side-by-side financial comparison of PHOTRONICS INC (PLAB) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $210.4M, roughly 1.4× PHOTRONICS INC). Bio-Techne runs the higher net margin — 12.8% vs 10.9%, a 2.0% gap on every dollar of revenue. On growth, PHOTRONICS INC posted the faster year-over-year revenue change (-5.5% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -3.8%).
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PLAB vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $210.4M | $295.9M |
| Net Profit | $22.9M | $38.0M |
| Gross Margin | 33.7% | 64.6% |
| Operating Margin | 22.9% | 18.4% |
| Net Margin | 10.9% | 12.8% |
| Revenue YoY | -5.5% | -6.4% |
| Net Profit YoY | -32.4% | 68.3% |
| EPS (diluted) | $0.39 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $210.4M | — | ||
| Q2 25 | $211.0M | $317.0M | ||
| Q1 25 | $212.1M | $316.2M | ||
| Q4 24 | $222.6M | $297.0M | ||
| Q3 24 | $211.0M | $289.5M | ||
| Q2 24 | $217.0M | $306.1M | ||
| Q1 24 | $216.3M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $22.9M | — | ||
| Q2 25 | $8.9M | $-17.7M | ||
| Q1 25 | $42.9M | $22.6M | ||
| Q4 24 | $33.9M | $34.9M | ||
| Q3 24 | $34.4M | $33.6M | ||
| Q2 24 | $36.3M | $40.6M | ||
| Q1 24 | $26.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 36.9% | 62.7% | ||
| Q1 25 | 35.6% | 67.9% | ||
| Q4 24 | 37.0% | 65.3% | ||
| Q3 24 | 35.6% | 63.2% | ||
| Q2 24 | 36.5% | 66.4% | ||
| Q1 24 | 36.6% | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 22.9% | — | ||
| Q2 25 | 26.4% | -7.5% | ||
| Q1 25 | 24.6% | 12.2% | ||
| Q4 24 | 25.1% | 16.0% | ||
| Q3 24 | 24.7% | 13.8% | ||
| Q2 24 | 25.8% | 15.0% | ||
| Q1 24 | 26.6% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 10.9% | — | ||
| Q2 25 | 4.2% | -5.6% | ||
| Q1 25 | 20.2% | 7.1% | ||
| Q4 24 | 15.2% | 11.7% | ||
| Q3 24 | 16.3% | 11.6% | ||
| Q2 24 | 16.7% | 13.3% | ||
| Q1 24 | 12.1% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.39 | — | ||
| Q2 25 | $0.15 | $-0.11 | ||
| Q1 25 | $0.68 | $0.14 | ||
| Q4 24 | $0.54 | $0.22 | ||
| Q3 24 | $0.55 | $0.21 | ||
| Q2 24 | $0.58 | $0.26 | ||
| Q1 24 | $0.42 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $575.8M | $172.9M |
| Total DebtLower is stronger | $16.0K | $260.0M |
| Stockholders' EquityBook value | $1.1B | $2.0B |
| Total Assets | $1.8B | $2.5B |
| Debt / EquityLower = less leverage | 0.00× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $575.8M | — | ||
| Q2 25 | $558.4M | $162.2M | ||
| Q1 25 | $642.2M | $140.7M | ||
| Q4 24 | $640.7M | $177.5M | ||
| Q3 24 | $606.4M | $187.5M | ||
| Q2 24 | $559.9M | $152.9M | ||
| Q1 24 | $521.5M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $16.0K | — | ||
| Q2 25 | $19.0K | $346.0M | ||
| Q1 25 | $21.0K | $330.0M | ||
| Q4 24 | $25.0K | $300.0M | ||
| Q3 24 | $28.0K | $300.0M | ||
| Q2 24 | $2.5M | $319.0M | ||
| Q1 24 | $2.7M | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.1B | ||
| Q3 24 | $1.1B | $2.1B | ||
| Q2 24 | $1.0B | $2.1B | ||
| Q1 24 | $1.0B | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.6B | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | 0.18× | ||
| Q1 25 | 0.00× | 0.16× | ||
| Q4 24 | 0.00× | 0.14× | ||
| Q3 24 | 0.00× | 0.14× | ||
| Q2 24 | 0.00× | 0.15× | ||
| Q1 24 | 0.00× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.1M | — |
| Free Cash FlowOCF − Capex | $25.2M | — |
| FCF MarginFCF / Revenue | 12.0% | — |
| Capex IntensityCapex / Revenue | 11.8% | — |
| Cash ConversionOCF / Net Profit | 2.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $64.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $50.1M | — | ||
| Q2 25 | $31.5M | $98.2M | ||
| Q1 25 | $78.5M | $41.1M | ||
| Q4 24 | $68.4M | $84.3M | ||
| Q3 24 | $75.1M | $63.9M | ||
| Q2 24 | $76.5M | $75.5M | ||
| Q1 24 | $41.5M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $25.2M | — | ||
| Q2 25 | $-29.1M | $93.3M | ||
| Q1 25 | $43.3M | $31.0M | ||
| Q4 24 | $25.2M | $77.5M | ||
| Q3 24 | $50.7M | $54.7M | ||
| Q2 24 | $56.5M | $57.5M | ||
| Q1 24 | $-1.8M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | -13.8% | 29.4% | ||
| Q1 25 | 20.4% | 9.8% | ||
| Q4 24 | 11.3% | 26.1% | ||
| Q3 24 | 24.0% | 18.9% | ||
| Q2 24 | 26.0% | 18.8% | ||
| Q1 24 | -0.8% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 28.7% | 1.5% | ||
| Q1 25 | 16.6% | 3.2% | ||
| Q4 24 | 19.4% | 2.3% | ||
| Q3 24 | 11.6% | 3.2% | ||
| Q2 24 | 9.2% | 5.9% | ||
| Q1 24 | 20.0% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 2.19× | — | ||
| Q2 25 | 3.55× | — | ||
| Q1 25 | 1.83× | 1.82× | ||
| Q4 24 | 2.02× | 2.42× | ||
| Q3 24 | 2.18× | 1.90× | ||
| Q2 24 | 2.11× | 1.86× | ||
| Q1 24 | 1.59× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
